Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 21, 2014; 20(19): 5773-5793
Published online May 21, 2014. doi: 10.3748/wjg.v20.i19.5773
Autophagy in hepatitis C virus-host interactions: Potential roles and therapeutic targets for liver-associated diseases
Po-Yuan Ke, Steve S-L Chen
Po-Yuan Ke, Steve S-L Chen, Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan
Po-Yuan Ke, Department of Biochemistry and Molecular Biology, Graduate Institute of Biomedical Sciences, and Molecular Medicine Research Center, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
Po-Yuan Ke, Liver Research Center, Chang-Gung Memorial Hospital, Taoyuan 33305, Taiwan
Steve S-L Chen, PhD Program in Translational Medicine, Kaohsiung Medical University, Kaohsiung 80708 and Academia Sinica, Taipei 11529, Taiwan
Author contributions: Ke PY and Chen SSL wrote the paper.
Correspondence to: Steve S-L Chen, PhD, Research Fellow, Institute of Biomedical Sciences, Academia Sinica, Nangang District, Taipei 11529, Taiwan. schen@ibms.sinica.edu.tw
Telephone: +886-2-2652-3933 Fax: +886-2-2652-3073
Received: October 8, 2013
Revised: January 14, 2014
Accepted: March 4, 2014
Published online: May 21, 2014
Processing time: 222 Days and 1.9 Hours
Abstract

Autophagy is a lysosome-associated, degradative process that catabolizes cytosolic components to recycle nutrients for further use and maintain cell homeostasis. Hepatitis C virus (HCV) is a major cause of chronic hepatitis, which often leads to end-stage liver-associated diseases and is a significant burden on worldwide public health. Emerging lines of evidence indicate that autophagy plays an important role in promoting the HCV life cycle in host cells. Moreover, the diverse impacts of autophagy on a variety of signaling pathways in HCV-infected cells suggest that the autophagic process is required for balancing HCV-host cell interactions and involved in the pathogenesis of HCV-related liver diseases. However, the detailed molecular mechanism underlying how HCV activates autophagy to benefit viral growth is still enigmatic. Additionally, how the autophagic response contributes to disease progression in HCV-infected cells remains largely unknown. Hence, in this review, we overview the interplay between autophagy and the HCV life cycle and propose possible mechanisms by which autophagy may promote the pathogenesis of HCV-associated chronic liver diseases. Moreover, we outline the related studies on how autophagy interplays with HCV replication and discuss the possible implications of autophagy and viral replication in the progression of HCV-induced liver diseases, e.g., steatosis and hepatocellular carcinoma. Finally, we explore the potential therapeutics that target autophagy to cure HCV infection and its related liver diseases.

Keywords: Autophagy; Hepatitis C virus; Steatosis; Cirrhosis; Hepatocellular carcinoma

Core tip: Hepatitis C virus (HCV) is a major cause of chronic liver disease and is associated with over 170 million infected individuals worldwide. However, a successful strategy for completely eradicating HCV infection is still limited. Autophagy is a catabolic process that delivers cytosolic components to lysosomes for breakdown. HCV has been shown to activate autophagy to promote viral growth in vitro. In this review, we outline the recent findings on the physiological significance of autophagy in the HCV life cycle and propose a potential role of autophagy in the development of HCV-related liver diseases as well as a perspective on therapeutics targeting autophagy to cure HCV infection.